4013.SR Stock — Price, Charts & Analysis

Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) has a trailing P/E of 34.41x and a forward P/E of 31.66x. This places 4013.SR in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

4013.SR trades with 34.41x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether 4013.SR looks overvalued or undervalued.

4013.SR's P/E of 34.41x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

4013.SR's trailing EPS is SAR 6.91 and forward EPS is SAR 7.51. Reported earnings growth is 12.10%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Dr. Sulaiman Al Habib Medical Services Group Company generated for each share. 4013.SR's trailing EPS is SAR 6.91, and investors usually prefer EPS that is positive and growing over time.

Dr. Sulaiman Al Habib Medical Services Group Company has a market cap of SAR 83.23B, making 4013.SR a large-cap stock based on the current market value shown on Worldtickers.

4013.SR's latest stock price on Worldtickers is SAR 237.80. The latest move is -SAR 0.60 or -0.25%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

4013.SR's quote includes a latest price of SAR 237.80. The market open is SAR 238.10. Previous close is SAR 238.40. The intraday range is SAR 235.50 to SAR 238.20.

4013.SR is down in the latest quote, with a move of -SAR 0.60 or -0.25%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

4013.SR generated SAR 14.61B in trailing revenue. Revenue growth is 18.40%, which helps show whether demand is expanding or slowing.

4013.SR's revenue growth is 18.40%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, 4013.SR shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is SAR 2.42B.

Gross margin is 29.28%. Margins show how efficiently Dr. Sulaiman Al Habib Medical Services Group Company turns revenue into profit.

Dr. Sulaiman Al Habib Medical Services Group Company carries SAR 9.67B and holds SAR 2.32B in cash.

4013.SR holds SAR 2.32B on its balance sheet.

4013.SR's book value per share is SAR 23.60.

Yes, Dr. Sulaiman Al Habib Medical Services Group Company pays a dividend of SAR 5.32 per share annually. The dividend yield is 223.00%. The payout ratio is 68.31%.

4013.SR's dividend yield is 223.00%. Its payout ratio is 68.31%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for 4013.SR. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Dr. Sulaiman Al Habib Medical Services Group Company's investor relations materials.

4013.SR's five-year average dividend yield is 160.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 4.43% of 4013.SR shares. Insiders hold 70.88% of shares. Ownership mix helps investors understand how much of Dr. Sulaiman Al Habib Medical Services Group Company is held by professional investors and company insiders.

4013.SR has 350M shares outstanding. Float shares are 101.99M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for 4013.SR, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for 4013.SR is SAR 7.51. Earnings growth is 12.10%. Revenue growth is 18.40%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

4013.SR's trailing EPS is SAR 6.91. Forward EPS is SAR 7.51. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

4013.SR is in the Healthcare sector. Its earnings multiple is 34.41x. Its latest displayed growth metric is 18.40%. Compare these figures with sector peers before deciding whether Dr. Sulaiman Al Habib Medical Services Group Company is stronger or weaker than average.

4013.SR trades at SAR 237.80. The stock trades at 34.41x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Dr. Sulaiman Al Habib Medical Services Group Company's fundamentals.

4013.SR risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.05, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

4013.SR should be compared with companies in Medical Care Facilities. Its earnings multiple is 34.41x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) operates in Healthcare, specifically Medical Care Facilities. Dr. Sulaiman Al Habib Medical Services Group Company, together with its subsidiaries, provides private health and support services in the Kingdom of Saudi Arabia. It operates through three segments: Hospitals/Healthcare Facilities, Pharmacies, and Other Solutions Sector. The company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities. It also provides home medical care; specialized medical laboratories; information technology an

4013.SR trades on Saudi. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

4013.SR stock is priced in SAR on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Dr. Sulaiman Al Habib Medical Services Group Company's official website listed on Worldtickers is hmg.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Dr. Sulaiman Al Habib Medical Services Group Company is headquartered in Riyadh, Saudi Arabia. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

4013.SR is in the Healthcare sector and the Medical Care Facilities industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

4013.SR has traded between SAR 210.10 and SAR 281.20 over the past 52 weeks. At SAR 237.80, it is 15.43% below the high and 13.18% above the low. The 52-week range helps gauge long-term price momentum.

4013.SR is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is SAR 221.27 and its 200-day moving average is SAR 237.45.

4013.SR's RSI is 66.45. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

4013.SR's latest RSI reading is 66.45, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for 4013.SR is near SAR 210.40. Key resistance is near SAR 241.90. Breaks above resistance or below support can change the short-term technical setup.

4013.SR's nearest reported support level is SAR 210.40. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

4013.SR's nearest reported resistance level is SAR 241.90. A breakout above resistance can improve momentum, especially when volume confirms the move.

4013.SR trades about 172.13K shares daily on average. The latest displayed volume is 59.15K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

4013.SR's MACD is -0.27, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

4013.SR is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 66.45 (neutral). MACD is bearish. Nearest support is around SAR 210.40. Resistance is around SAR 241.90. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is SAR 232.38 (2.59% from price). MA50 is SAR 221.27 (7.74% from price). MA200 is SAR 237.45 (0.40% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. 4013.SR's MA20 is SAR 232.38. MA50 is SAR 221.27. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

4013.SR's pivot is near SAR 234.23. Support is near SAR 210.40. Resistance is near SAR 241.90. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for 4013.SR is near SAR 227.40. The next upper resistance zone is near SAR 242.65. These levels help define risk and possible follow-through zones after a breakout or breakdown.

4013.SR's Bollinger range is roughly SAR 220.46 to SAR 244.29. Band width is near 10.26%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

4013.SR's ATR-based typical daily range is about 1.75%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 59.15K shares. Average volume is about 172.13K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

4013.SR's all-time high shown on Worldtickers is SAR 346.80. Its all-time low is SAR 51.90. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

4013.SR has a beta of 0.05, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.